Trials / Completed
CompletedNCT01350778
Evaluation of Effectiveness and Safety of BIOMATRIX Stent (IRIS-BIOMATRIX)
Evaluation of Effectiveness and Safety of BIOMATRIX in Routine Clinical Practice; A Multicenter, Prospective Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 837 (actual)
- Sponsor
- Seung-Jung Park · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate effectiveness and safety of BioMatrix stent in the "real world" daily practice as compared with first-generation drug-eluting stents (sirolimus- or paclitaxel-eluting stents).
Detailed description
This study is a non-randomized, prospective, open-label registry to compare the efficacy and safety of BioMatrix stents versus first-generation drug-eluting stent (DES) in patients with coronary artery disease.
Conditions
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2016-07-01
- Completion
- 2020-08-14
- First posted
- 2011-05-10
- Last updated
- 2021-01-27
Locations
20 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01350778. Inclusion in this directory is not an endorsement.